Endocrinol Metab.  2011 Mar;26(1):106-107. 10.3803/EnM.2011.26.1.106.

Letter: The Effects of Combined Treatment of Alendronate Plus Active or Plain Vitamin D on the Vitamin D Metabolism and Bone Turnover Marker in Patients with Osteoporosis (Endocrinol Metab 25:305-309, 2010, Jee-Hoon Koo et al.)

• Chang SA

• KMID: 2169135
• DOI: http://doi.org/10.3803/EnM.2011.26.1.106

Abstract

No abstract available.

MeSH Terms

Alendronate
Humans
Osteoporosis
Vitamin D
Vitamins
Alendronate
Vitamin D
Vitamins

Reference

1. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev. 1986. 7:434–448.

2. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007. 1–235.

3. Ringe JD, Schacht E. Potential of alfacalcidol for reducing increased risk of falls and fractures. Rheumatol Int. 2009. 29:1177–1185.

4. Ringe JD, Farahmand P, Schacht E, Rozehnal A. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int. 2007. 27:425–434.